Because the data [are] contextualized, we know who the physicians are [that are] working with the patients we aspire to treat ...

Experts at SCOPE Europe 2025 confronted the challenges posed by rapid trial proliferation, digital transformation and ...

Ottawa, Oct. 13, 2025 (GLOBE NEWSWIRE) -- The global clinical trial design market size was valued at USD 567.66 million in 2024 and is predicted to hit around USD 1,228.57 million by 2034, rising at a ...

Speakers at the 2024 World Conference on Lung Cancer discussed the considerations that must go into designing and performing clinical trials in the early-stage lung cancer space, ranging from ...

Akebia (AKBA) announced that after meeting with the FDA it has not come to alignment on a path forward for the design of the VALOR clinical trial ...

While most of what the FDA laid out in a recent draft guidance on the assessment of overall survival in oncology clinical ...

At OCTSC, an expert delved into how to optimise patient enrollment to achieve retention and clinical trial success.

BOSTON--(BUSINESS WIRE)--Seaport Therapeutics (“Seaport” or the “Company”), a clinical-stage biopharmaceutical company that is advancing novel neuropsychiatric medicines with a proven strategy and ...

Breast cancer is the most-researched disease, yet only 14% of trials reach optimal enrollment, highlighting a significant gap in clinical trial participation. COVID-19 has increased trial attrition ...

Despite being a cornerstone of cancer treatment advancement, clinical trials remain inaccessible for many patients because of structural, socioeconomic, and systemic barriers. In this ...

The world's largest-ever clinical trial of treatments to slow or stop the progression of Parkinson's disease has launched, ...